116 related articles for article (PubMed ID: 36215974)
1. Association of Cancer Antigen 125 with Long-Term Prognosis in Light-Chain Cardiorenal Amyloidosis.
Wu B; Shi J; Yu F; Wu Y; Tao X; Xuan T; Yang J; Wang X
Cardiorenal Med; 2023; 13(1):19-25. PubMed ID: 36215974
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.
Kouris NT; Kontogianni DD; Papoulia EP; Goranitou GS; Zaharos ID; Grassos HA; Kalkandi EM; Sifaki MD; Babalis DK
Hellenic J Cardiol; 2006; 47(5):269-74. PubMed ID: 17134062
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
[TBL] [Abstract][Full Text] [Related]
5. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Right Ventricular Dysfunction in Patients With AL Amyloidosis: Comparison of Different Techniques by Cardiac Magnetic Resonance.
Wan K; Lin J; Guo X; Song R; Wang J; Xu Y; Li W; Cheng W; Sun J; Zhang Q; Han Y; Chen Y
J Magn Reson Imaging; 2020 Nov; 52(5):1441-1448. PubMed ID: 32691470
[TBL] [Abstract][Full Text] [Related]
10. CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
Soler M; Miñana G; Santas E; Núñez E; de la Espriella R; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; D'Ascoli G; Marti-Cervera J; Sanchis J; Bayes-Genís A; Núñez J
Int J Cardiol; 2020 Jun; 308():54-59. PubMed ID: 32209267
[TBL] [Abstract][Full Text] [Related]
11. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters.
Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK
Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467
[TBL] [Abstract][Full Text] [Related]
12. Independent prognostic value of left ventricular mass index in patients with light-chain amyloidosis.
Huang H; He H; Qin Y; Du J; Song J
Acta Cardiol; 2022 Nov; 77(9):815-821. PubMed ID: 36196999
[TBL] [Abstract][Full Text] [Related]
13. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal syndrome as predictor of in-hospital mortality in ST-segment elevation myocardial infarction.
Rodríguez-Jiménez AE; Negrín-Valdés T; Cruz-Inerarity H; Machural-de la Torre PJ
Clin Investig Arterioscler; 2018; 30(4):163-169. PubMed ID: 29599092
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of morphological and functional parameters of cardiac magnetic resonance in patients with systemic light chain amyloidosis].
Miao FJ; Tang CX; Chen WC; Ren GS; Guo JZ; Zhao L; Zhou XY; Zhang LJ; Huang XH
Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(7):506-512. PubMed ID: 36800774
[No Abstract] [Full Text] [Related]
17. Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in Patients with Systemic Light Chain Amyloidosis.
Yuda S; Hayashi T; Yasui K; Muranaka A; Ohnishi H; Hashimoto A; Ishida T; Tsuchihashi K; Shinomura Y; Watanabe N; Miura T
Intern Med; 2015; 54(15):1833-40. PubMed ID: 26234222
[TBL] [Abstract][Full Text] [Related]
18. Serum carbohydrate antigen 125 levels in nonischemic dilated cardiomyopathy: a useful biomarker for prognosis and functional mitral regurgitation.
Karaca O; Guler GB; Guler E; Gunes HM; Alizade E; Agus HZ; Gol G; Kahveci G; Esen O; Esen AM; Turkmen M
Congest Heart Fail; 2012; 18(3):144-50. PubMed ID: 22587744
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]